Jude Onyia sold $2.6M of Neurocrine Biosciences (NBIX)

Executed Jul 2 2025, disclosed Jul 7 2025, 5 days later.

Value, as filed

$2.6M

20,362 sh × $130.13

Executed

Jul 2 2025

the trade date, as filed

Disclosed

Jul 7 2025

5 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

JO Jude Onyia Chief Scientific Officer profile →

Jude Onyia (Chief Scientific Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Neurocrine Biosciences, Inc. (NBIX). The largest single filing was $1.8M of NBIX (11,000 sh × $160.25, as filed), executed Jun 1.

The name

NBIX Neurocrine Biosciences, Inc. NBIX · Healthcare · 59 filings in 24 months ticker →

Healthcare · Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunolog…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Jude Onyia in NBIX

NBIXSALE Neurocrine Biosciences, Inc. $1.8M
11,000 sh × $160.25
Exec Jun 1
Filed Jun 2 · 5:30 PM ET NBIXSALE Neurocrine Biosciences, Inc. $1.7M
11,000 sh × $155.53
Exec May 27
Filed May 29 · 5:30 PM ET NBIXSALE Neurocrine Biosciences, Inc. $7.8M
59,819 sh × $130.46
Exec Jul 9 2025
Filed Jul 11 2025 · 5:30 PM ET NBIXSALE Neurocrine Biosciences, Inc. $336K
2,879 sh across 2 lots
Exec Feb 13 2025
Filed Feb 14 2025 · 5:30 PM ET NBIXSALE Neurocrine Biosciences, Inc. $294K
2,331 sh × $126.29
Exec Nov 29 2024
Filed Dec 3 2024 · 5:30 PM ET